We analyzed EZH2 mRNA expression in a cohort of 131 CLL cases of whom 75 (57.3%) and 56 (42.7%) concerned M-CLL and U-CLL, respectively. The gene discussed is EZH2; the disease is B-cell chronic lymphocytic leukemia.